Waldenström macroglobulinemia: a review of therapy.
Waldenström macroglobulinemia is a rare monoclonal gammopathy-associated lymphoplasmacytic lymphoma. Its incidence is only 4 per million per year. This review contains the known published literature specifically on the available management tools for Waldenström macroglobulinemia and is designed to assist clinicians in making management decisions for patients with this uncommon disorder.
Gertz
Morie A
MA
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA. gertz.morie@mayo.edu
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006801:Humans; D010951:Plasma Exchange; D033581:Stem Cell Transplantation; D014182:Transplantation, Autologous; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy / Q000628:therapy*